Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.71 |
| ▸ | MAPT | P10636 | 4/20 | 0.71 |
| ▸ | MAOB | P27338 | 1/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.70 |
| ▸ | NPC1 | O15118 | 6/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.70 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.70 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.70 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.66 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.61 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.61 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6341485 | 0.95 | SMN1; SMN2 (0.65) | RAB9AMAPTMAOBSMN1; SMN2NPC1 | |
| SCHEMBL9343582 | 0.95 | SMN1; SMN2 (0.65) | RAB9AMAPTMAOBSMN1; SMN2NPC1 | |
| SCHEMBL6162284 | 0.93 | SMN1; SMN2 (0.79) | RAB9AMAPTMAOBSMN1; SMN2NPC1 | |
| SCHEMBL11350421 | 0.91 | RAB9A (0.82) | RAB9AMAPTMAOBSMN1; SMN2NPC1 | |
| SCHEMBL10236929 | 0.91 | RAB9A (0.82) | RAB9AMAPTMAOBSMN1; SMN2NPC1 | |
| SCHEMBL1122731 | 0.91 | SMN1; SMN2 (0.64) | RAB9AMAPTMAOBSMN1; SMN2NPC1 | |
| SCHEMBL27395439 | 0.91 | RAB9A (0.68) | RAB9AMAPTMAOBSMN1; SMN2NPC1 | |
| SCHEMBL7776764 | 0.89 | RAB9A (0.65) | RAB9AMAPTMAOBSMN1; SMN2NPC1 | |
| SCHEMBL6255833 | 0.89 | L3MBTL1 (0.62) | RAB9AMAPTMAOBSMN1; SMN2NPC1 | |
| SCHEMBL898771 | 0.89 | RXRA (0.77) | RAB9AMAPTSMN1; SMN2NPC1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234918-A1 | AUTOMATED DIAZOMETHANE GENERATOR, REACTOR AND SOLID PHASE QUENCHER | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2023-07-27 | — | — | US | claimed |
| EP-4178942-A1 | AUTOMATED DIAZOMETHANE GENERATOR, REACTOR AND SOLID PHASE QUENCHER | Council Of Scientific & Industrial Research (IN) | 2023-05-17 | — | — | EP | claimed |
| CN-115956066-A | Automatic diazomethane generator, reactor and solid phase quenching agent | 科学与工业研究委员会 | 2023-04-11 | — | — | CN | claimed |
| WO-2022044038-A1 | AUTOMATED DIAZOMETHANE GENERATOR, REACTOR AND SOLID PHASE QUENCHER | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-03 | — | — | WO | claimed |
| JP-59129194-A | — | — | None | — | — | JP | disclosed |
| US-20250367143-A1 | MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 | ACADIA PHARM INC (US) | 2025-12-04 | — | — | US | disclosed |
| WO-2025244832-A1 | NOVEL AMINOGUANIDINE DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF | KONG'S PHARMACEUTICAL CO. (US) | 2025-11-27 | — | — | WO | disclosed |
| EP-4543848-A1 | MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 | ACADIA Pharmaceuticals Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| CN-118307534-A | LTA4H inhibitors and uses thereof | 上海海雁医药科技有限公司 | 2024-07-09 | — | — | CN | disclosed |
| US-20240116897-A1 | BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2024-04-11 | — | — | US | disclosed |
| WO-2023250059-A1 | MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 | ACADIA PHARMACEUTICALS INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| EP-4269394-A1 | BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | Korea Research Institute of Chemical Technology (KR) | 2023-11-01 | — | — | EP | disclosed |
| EP-0312604-A1 | 1-(2-(4-HYDROXYBENZOYL)ETHANOYL)-2-PIPERIDONE, PROCESS FOR ITS PREPARATION, AND ALCOHOLIC FERMENTATION ACCELERATOR CONTAINING IT AS EFFECTIVE INGREDIENT | TAKI CHEMICAL CO., LTD. (JP) | 1989-04-26 | — | — | EP | disclosed |
| US-4682193-A | HEAT SENSITIVE, STORAGE STABILITY | FUJI PHOTO FILM CO., LTD. (JP) | 1987-07-21 | — | — | US | disclosed |
| US-4672071-A | Antihypertensive dihydropyridine compositions, optical isomers and intermediates | SYNTEX (U.S.A.) INC. (US) | 1987-06-09 | — | — | US | disclosed |
| EP-0199042-A1 | Procainamide assay, tracers, immunogens and antibodies | ABBOTT LABORATORIES (US) | 1986-10-29 | — | — | EP | disclosed |
| EP-0191448-A2 | Antihypertensive dihydropyridine derivatives | SYNTEX (U.S.A.) INC. (US) | 1986-08-20 | — | — | EP | disclosed |
| US-4595690-A | Hypotensive agents | SYNTEX (U.S.A.) INC. (US) | 1986-06-17 | — | — | US | disclosed |
| JP-S59129194-A | HEAT SENSITIVE RECORDING PAPER | YOSHITOMI PHARMACEUT IND LTD | 1984-07-25 | — | — | JP | disclosed |
| US-4098816-A | HYPOGLYCEMIC AGENTS AND ANTILIPEMIC AGENTS | BEECHAM GROUP LIMITED (GB) | 1978-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250367143-A1 | MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 | GPR88, GPR84, GPR68 | RAB9A 795/4885MAPT 188/4885MAOB 1932/4885 |
| US-20240116897-A1 | BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | SIRT7, SIRT1, BRD7 | RAB9A 2738/4885MAPT 957/4885MAOB 4450/4885 |
| US-20230234918-A1 | AUTOMATED DIAZOMETHANE GENERATOR, REACTOR AND SOLID PHASE QUENCHER | FTO, MNAT1, ALKBH2 | RAB9A 4756/4885MAPT 2101/4885MAOB 508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.